FDA Drug Safety Initiative Will Include New Website On Rx Risks

The site is intended as an avenue for the agency to disclose safety issues that have not yet been definitively reviewed, and to emphasize the risks with all prescription drugs. The website proposal is understood to be in the internal agency review phase.

More from Archive

More from Pink Sheet